Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2020-08-28
Original market date: See footnote 1
2005-01-27
Lot number: See footnote 2
19AM191
Expiry date: See footnote 2
2020-11-30
Product name:
TRI-CYCLEN LO (21 DAY)
DIN:
02258560
Product Monograph/Veterinary Labelling:
Date:
2020-03-03
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
JANSSEN INC
19 Green Belt Drive
Toronto
Ontario
Canada
M3C 1L9
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
6
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
68:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
G03AB11 NORGESTIMATE AND ESTROGEN
Active ingredient group (AIG) number:See footnote5
0636783003
Active ingredient(s) | Strength |
---|---|
ETHINYL ESTRADIOL | 0.025 MG |
ETHINYL ESTRADIOL | 0.025 MG |
ETHINYL ESTRADIOL | 0.025 MG |
NORGESTIMATE | 0.180 MG |
NORGESTIMATE | 0.215 MG |
NORGESTIMATE | 0.250 MG |